COFOE MEDICAL (01187.HK): Addresses Rationale for A-Share Buyback and H-Share Controlling Shareholder Increase; Seven Philips-Licensed Categories Gearing for Launch
NewTimeSpace News: On 2 September 2026, Cofoe Medical Technology Co., Ltd. (stock code: 01187.HK) published an overseas regulatory announcement setting out its investor relations activity record (No. 2026-007) posted on the Shenzhen Stock Exchange website and cninfo.com.cn. The record summarized the company's results briefing held the same day via an online session on the Panorama investor relations platform.
Regarding the strategic rationale for the A-share buyback and the H-share increase by the controlling shareholder, the company said the A-share buyback was its second this year and all repurchased shares would be cancelled, reducing total share capital and directly lifting key metrics such as earnings per share and return on equity while enhancing shareholders' interests; the controlling shareholder's concurrent H-share increase reflected confidence in the company's long-term development value and growth space in its core tracks. The company noted that its core product lines, including respiratory support, health monitoring and rehabilitation devices, are growing steadily, with innovations such as the C11 ventilator, continuous glucose monitoring system and Philips-launched products continuing to roll out.
On Philips cooperation, the company has obtained brand licensing from Philips for seven health monitoring categories in Greater China — blood glucose meters, blood pressure monitors, continuous glucose monitors (CGM), thermometers, pulse oximeters, spirometers and body weight scales — with the first batch of products having completed registration and certification as well as production line construction, and preparations for launch progressing. In addition, the company had approximately 15,000 shareholders in total as of 31 August 2026.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
